Postmarketing commitments for novel drugs and biologics approved by the US Food and Drug Administration: a cross-sectional analysis

Overview of attention for article published in BMC Medicine, June 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

news: 3 news outlets

twitter: 24 X users

Readers on

mendeley: 23 Mendeley

So far, Altmetric has seen 41 X posts from 24 X users, with an upper bound of 106,467 followers.

@ENirenberg Because I keep reading things like this? https://t.co/6EpMCQ4Tlj https://t.co/2SmXjgS0Lm https://t.co/A32HuVPRna

Reply Repost Favourite

In previous studies, we evaluated the types of PMRs/PMCs & rates of completion (ie, results reporting on https://t.co/yxwqaPMA7r / in publications) for new drugs/biologics approved 2009-12. 3/10 https://t.co/tgRnl4oWbL https://t.co/kleCrc3Xgs

Reply Repost Favourite

3/ We've studied the rates/timeliness of registration and results reporting (https://t.co/yxwqaPuZfT) and publication of clinical PMRs and PMCs: https://t.co/kleCrclyF2, https://t.co/tgRnl4GxAl, and https://t.co/hpAdZfNOts, outlining a # of transparency/di

Reply Repost Favourite

@kaulcsmc @hmkyale @YaleMed @Dr_BowTie65 If interested, we've studied this a bit more on the drug side (led by @JoshuaDWallach): https://t.co/MASS9LjXOo, https://t.co/xM3FdLr5Sv, https://t.co/dTMjHG99E7 and https://t.co/RHTzqoclcs.

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 37 additional X posts.